Patient-centered, Optimal Integration of Survivorship and Palliative Care

Clinical trial NCT04900935 · RECRUITING

Trial details

NCT number: NCT04900935
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Stage IV Non-small Cell Lung Cancer Targeted Therapy Nonsmall Cell Lung Cancer Carcinoma, Non-Small-Cell Lung ALK-positive Non-small Cell Lung Cancer EGFR Positive Non-small Cell Lung Cancer Palliative Care Survivorship

Start date: 2023-09-29
Primary completion: 2027-06-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.